Characterization of the myddosome, a protein complex that controls TLR signaling

myddosome(一种控制 TLR 信号传导的蛋白质复合物)的表征

基本信息

  • 批准号:
    9236656
  • 负责人:
  • 金额:
    $ 44.25万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2016
  • 资助国家:
    美国
  • 起止时间:
    2016-12-13 至 2020-11-30
  • 项目状态:
    已结题

项目摘要

Project Summary: The goal of this proposal is to characterize a protein complex called the myddosome, which is uniquely assembled during Toll-like Receptor (TLR) signal transduction. The myddosome is one of several newly- defined receptor-proximal complexes that control innate immune signal transduction. Analogous complexes operate to control inflammasome assembly and the RIG-I and TNF receptor signaling pathways. A common feature of these complexes is that they operate as organelles that are assembled “on-demand”, or upon ligand binding. As such, these complexes are only present in cells after microbes have been detected, and they may serve as critical hubs for coordinating downstream signaling enzyme activation. Despite the recognition that these organelles control innate immunity, we have little understanding of their regulation (or composition). Our proposal is founded on our recent discovery that the myddosome is assembled within macrophages upon treatment with TLR ligands. This finding is important because it had been unclear whether the myddosome is a pre-existing protein complex, or if it is assembled inducibly. The inducible assembly of this complex provided us with a tool to study its regulation, and we recently identified the TLR sorting adaptor TIRAP as the first regulator of myddosome assembly. These discoveries establish the myddosome as an important model to study receptor-proximal protein complexes that define the signaling pathways of the innate immune system. In this application, we propose to explore how known myddosome components interact to regulate TLR signaling in vitro and in vivo (Aim 1), to explore how a new myddosome component regulates TLR signaling (Aim 2), and to explore the mechanisms underlying several mutant myddosome components that cause mouse or human disease (Aim 3).
项目总结:

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JONATHAN C KAGAN其他文献

JONATHAN C KAGAN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JONATHAN C KAGAN', 18)}}的其他基金

Regulation of immunity by the cGAS-STING pathway
cGAS-STING 通路对免疫的调节
  • 批准号:
    10583763
  • 财政年份:
    2022
  • 资助金额:
    $ 44.25万
  • 项目类别:
Regulation of immunity by the cGAS-STING pathway
cGAS-STING 通路对免疫的调节
  • 批准号:
    10707202
  • 财政年份:
    2022
  • 资助金额:
    $ 44.25万
  • 项目类别:
Defining the pathways activated by Toll-like Receptors to stimulate immunity
定义 Toll 样受体激活的途径以刺激免疫力
  • 批准号:
    10209029
  • 财政年份:
    2016
  • 资助金额:
    $ 44.25万
  • 项目类别:
Defining the pathways activated by Toll-like Receptors to stimulate immunity
定义 Toll 样受体激活的途径以刺激免疫力
  • 批准号:
    10553667
  • 财政年份:
    2016
  • 资助金额:
    $ 44.25万
  • 项目类别:
Initiation and regulation of antibacterial innate immunity
抗菌先天免疫的启动和调节
  • 批准号:
    8891586
  • 财政年份:
    2014
  • 资助金额:
    $ 44.25万
  • 项目类别:
Defining non-transcriptional innate immune responses to bacterial endotoxin
定义对细菌内毒素的非转录先天免疫反应
  • 批准号:
    8660126
  • 财政年份:
    2013
  • 资助金额:
    $ 44.25万
  • 项目类别:
Initiation and Regulation of Antiviral Innate Immunity
抗病毒先天免疫的启动和调节
  • 批准号:
    8434005
  • 财政年份:
    2011
  • 资助金额:
    $ 44.25万
  • 项目类别:
Initiation and Regulation of Antiviral Innate Immunity
抗病毒先天免疫的启动和调节
  • 批准号:
    8223165
  • 财政年份:
    2011
  • 资助金额:
    $ 44.25万
  • 项目类别:
Initiation and Regulation of Antiviral Innate Immunity
抗病毒先天免疫的启动和调节
  • 批准号:
    8824865
  • 财政年份:
    2011
  • 资助金额:
    $ 44.25万
  • 项目类别:
Initiation and Regulation of Antiviral Innate Immunity
抗病毒先天免疫的启动和调节
  • 批准号:
    8081944
  • 财政年份:
    2011
  • 资助金额:
    $ 44.25万
  • 项目类别:

相似海外基金

University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
  • 批准号:
    10073243
  • 财政年份:
    2024
  • 资助金额:
    $ 44.25万
  • 项目类别:
    Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
  • 批准号:
    10752129
  • 财政年份:
    2024
  • 资助金额:
    $ 44.25万
  • 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
  • 批准号:
    2339201
  • 财政年份:
    2024
  • 资助金额:
    $ 44.25万
  • 项目类别:
    Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
  • 批准号:
    MR/Y008693/1
  • 财政年份:
    2024
  • 资助金额:
    $ 44.25万
  • 项目类别:
    Research Grant
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
  • 批准号:
    10076445
  • 财政年份:
    2023
  • 资助金额:
    $ 44.25万
  • 项目类别:
    Grant for R&D
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
  • 批准号:
    23K14783
  • 财政年份:
    2023
  • 资助金额:
    $ 44.25万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
  • 批准号:
    23KJ0394
  • 财政年份:
    2023
  • 资助金额:
    $ 44.25万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Role of antibodies in hepatitis E virus infection
抗体在戊型肝炎病毒感染中的作用
  • 批准号:
    10639161
  • 财政年份:
    2023
  • 资助金额:
    $ 44.25万
  • 项目类别:
Defining the protective or pathologic role of antibodies in Post-Ebola Syndrome
定义抗体在埃博拉后综合症中的保护或病理作用
  • 批准号:
    10752441
  • 财政年份:
    2023
  • 资助金额:
    $ 44.25万
  • 项目类别:
Human CMV monoclonal antibodies as therapeutics to inhibit virus infection and dissemination
人 CMV 单克隆抗体作为抑制病毒感染和传播的治疗药物
  • 批准号:
    10867639
  • 财政年份:
    2023
  • 资助金额:
    $ 44.25万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了